Numazu, Japan

Hidetaka Kobayashi




Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Shizuoka, JP (2006 - 2009)
  • Numazu, JP (2006 - 2010)

Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Hidetaka Kobayashi: Innovator in Cancer Treatment

Introduction

Hidetaka Kobayashi is a prominent inventor based in Numazu, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 9 patents to his name, Kobayashi's work focuses on enhancing the effectiveness of DNA-damaging treatments for cancer.

Latest Patents

Kobayashi's latest patents include groundbreaking inventions related to compounds that abrogate DNA damage-induced cell cycle G2 checkpoints. These inventions provide compositions and methods to inhibit the G2 checkpoint in mammalian cells, including human cells. Specifically, his work aims to sensitize cells to DNA-damaging agents by abrogating the G2 checkpoint. The compounds developed by Kobayashi are intended for treating proliferative disorders such as cancer. His inventions also include methods for selectively sensitizing G1 checkpoint impaired cancer cells to DNA-damaging agents and treatments.

Career Highlights

Throughout his career, Hidetaka Kobayashi has worked with notable companies such as Canbas Co., Ltd. and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research in cancer treatment.

Collaborations

Kobayashi has collaborated with various professionals, including his coworker Takumi Kawabe. These partnerships have contributed to the advancement of his research and the development of innovative solutions for cancer treatment.

Conclusion

Hidetaka Kobayashi is a distinguished inventor whose work in cancer treatment has the potential to significantly impact the medical field. His innovative patents and collaborations demonstrate his commitment to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…